A patient's blood pressure reading in a clinic isn't always the full picture. Some patients run high in a doctor's office and are normal everywhere else, a pattern known as white coat syndrome. Others do the opposite and are normal in the office, but elevated at home. Both are common, and both can lead to the wrong treatment decision if a clinic reading is the only one a care team sees.
Clinic and Home Readings
White coat syndrome shows up in an estimated 15-30% of patients evaluated for high blood pressure in a clinical setting. Masked hypertension (reverse of white coat syndrome) is less talked about but equally concerning. Patients with masked hypertension have a similar risk of cardiovascular events as patients with sustained hypertension, and about 2x the risk of patients with normal blood pressure. If a care team only sees clinic readings, these patients may appear healthy, but are carrying hidden cardiovascular risk.
Home blood pressure monitoring is one of the few tools that can catch both patterns, since it captures what's happening outside of a clinical visit and other variables.
Accurate, Complete Blood Pressure Data Motivates Patients
Treatment decisions need to depend on knowing a patient's day-to-day blood pressure and not a one time office measurement. This can help prevent having a patient's treatment plan being built on data that might not be the full picture. In addition, patients are more motivated to make lifestyle changes and take their medications when treatment decisions are based on more than a single read. As Dr. Nisha Basu, a primary care physician and Withings Clinical Advisor states:
“Often a patient’s response to an elevated blood pressure in my office is ‘Oh I am just stressed today.’ When I can engage the patient in their home blood pressure values, I can show them that their blood pressure elevation is not an isolated incident. It helps to change the patient’s perception of how their body is working and motivates them to take the important steps to change it.”
Heart Failure Patients
The stakes are higher for patients recovering from a heart failure hospitalization. The first 30 to 90 days after discharge is the window where most readmissions happen, and it's also the window where blood pressure trends carry the most information. For these patients, a missed reading can point to an early shift in cardiac status, something a care team wants to catch before it turns into a hospital visit, but clinic visits happen too infrequently to catch it in time. Which is why BPM Pro 2's Patient Insights is built to capture symptoms and context as soon as the reading is taken, giving care teams a fuller picture. “Traditionally we have relied on the patient’s self-reported weight to make crucial clinical decisions after HF hospitalization. Being able to have reliable, daily weight data improves our outreach and management decisions.” says Dr. Basu.
Making Sure Home Data Can Be Trusted
A study published in Vascular Health and Risk Management tested BPM Pro 2 against the AAMI/ESH/ISO 81060-2:2018 protocol, which is the current global standard for validating automated blood pressure monitors. Researchers took blood pressure readings on the same arm, alternating between BPM Pro 2 and a manual mercury cuff (the traditional gold-standard method), then compared how closely the two matched, with BPM Pro 2 passing.
Independently validated devices like BPM Pro 2 put verified, clinically backed data at the foundation of the program they're part of. Care teams can rely on that data for decisions on medication, escalation reporting, and health alerts, without having to have the patient come to a clinic.
References
Zelveian P, Hakobyan Z, Topouchian J, Avagyan A, Gharibyan H, Asmar R. Accuracy of the Withings BPM Pro 2 (WPM07) Device for Self-Blood Pressure Measurements in the General Populations According to the International Organization for Standardization Universal Standard (ISO 81060-2:2018/AMD 2:2024) Protocol. Vascular Health and Risk Management, 2026.
International Organization for Standardization. ISO 81060-2:2018 — Non-invasive sphygmomanometers.
Franklin SS, et al. "White-Coat Hypertension: New Insights From Recent Studies." Hypertension. 2013;61(3):723-728: https://www.ahajournals.org/doi/10.1161/hypertensionaha.113.01275
American Medical Association. The validation of BP measurement devices for clinical accuracy